<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An increased association between <z:mpath ids='MPATH_366'>neuroendocrine tumors</z:mpath> of the gastrointestinal tract and pancreas (GEP-NET) and other <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary malignancies</z:e> has been suggested </plain></SENT>
<SENT sid="1" pm="."><plain>We determined whether there is indeed an increased risk for <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary malignancies</z:e> in GEP-NET patients compared with an age- and sex-matched control group of patients with identical <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The series comprised 243 men and 216 women, diagnosed with a GEP-NET between 2000 and 2009 in a tertiary referral center </plain></SENT>
<SENT sid="3" pm="."><plain>The timeline, before-at-after diagnosis, and the type of other <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> were studied using person-year methodology </plain></SENT>
<SENT sid="4" pm="."><plain>Poisson distributions were used for testing statistical significance </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> data were cross-checked with the Dutch National <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Registry </plain></SENT>
<SENT sid="6" pm="."><plain>Out of 459 patients with GEP-NET, 67 (13.7%) had a <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary cancer</z:e> diagnosis: 25 previous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (5.4%), 13 synchronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (2.8%), and 29 metachronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (6.3%) </plain></SENT>
<SENT sid="7" pm="."><plain>The most common types of <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary cancer</z:e> were <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (n=10), <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (n=8), <z:hpo ids='HP_0002861'>melanoma</z:hpo> (n=6), and <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> (n=5) </plain></SENT>
<SENT sid="8" pm="."><plain>The number of patients with a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> history was lower than expected, although not significant (n=25 vs n=34.5) </plain></SENT>
<SENT sid="9" pm="."><plain>The diagnosis of synchronous <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, mainly <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, was higher than expected (n=13 vs n=6.1, P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Metachronous <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> occurred as frequent as expected (n=29 vs n=25.2, NS) </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion, our results are in contrast to previous studies and demonstrate that only the occurrence of synchronous <z:e sem="disease" ids="C0751623" disease_type="Neoplastic Process" abbrv="">second primary malignancies</z:e>, mainly <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e>, is increased in GEP-NET patients compared with the general population </plain></SENT>
</text></document>